Company profile for Alimera Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alimera, founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera's commitment to retina specialists and their...
Alimera, founded in June 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. For more information, please visit www.alimerasciences.com.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6120 Windward Parkway Suite 290 Alpharetta, GA 30005
Telephone
Telephone
+1 (678) 990-5740
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/09/16/2946466/0/en/ANI-Pharmaceuticals-Initiates-Closing-of-Acquisition-of-Alimera-Sciences.html

GLOBENEWSWIRE
16 Sep 2024

https://www.globenewswire.com/news-release/2024/09/11/2944347/0/en/ANI-Pharmaceuticals-and-Alimera-Sciences-Announce-Closing-Date-of-Merger.html

GLOBENEWSWIRE
11 Sep 2024

https://www.globenewswire.com/news-release/2024/09/10/2944050/0/en/ANI-Pharmaceuticals-Provides-Update-on-Closing-of-Acquisition-of-Alimera-Sciences.html

GLOBENEWSWIRE
10 Sep 2024

https://www.globenewswire.com/news-release/2024/08/06/2924951/12565/en/Alimera-Sciences-Reports-Second-Quarter-2024-Results.html

GLOBENEWSWIRE
06 Aug 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-06-24/ani-pharmaceuticals-to-acquire-alimera-sciences/9769

CONTRACT PHARMA
24 Jun 2024

https://www.globenewswire.com/news-release/2024/06/04/2893463/12565/en/Alimera-Sciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
04 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty